BTA
Click for more information
0.00% 57.0¢ biota holdings limited

this from the Wilson report is a sad commentary really."GSK is...

  1. Craig The Speculator
    642 Posts.
    clock Created with Sketch.
    20/10/09
    23:28
    Post #: 5808017
    this from the Wilson report is a sad commentary really.


    "GSK is still ignoring the retail channel for Relenza. The most recent IMS Health data reports ~10-15 thousand US Relenza prescriptions, monthly."


    If so why? perhaps cause they dont have capacity yet
    BTA Price at posting: $2.88 Sentiment: ST Sell Disclosure: Not Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

EMR Emerald expands underground resource by 105Koz at Cambodian gold mine Okvau
right-arrow Created with Sketch.
NEWS Consumer Staples Shine Amid Retail Slump – Key Stocks to Watch
right-arrow Created with Sketch.
TLG Talga expands Prospectus Offer to $9M, banks $18.5M overall since end of financial year
right-arrow Created with Sketch.
EBR EBR reaches review milestone for wireless cardiac pacing device
right-arrow Created with Sketch.
NEWS Results wrap: Wesfarmers, Southern Cross Media, Qantas
right-arrow Created with Sketch.
HYT Twiggy Forrest to acquire 40% of native hydrogen explorer – not long after putting Fortescue Future Industries to sleep
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BTA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.